You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer

 

Online download statistics by month:

Online download statistics by month: March 2021 to June 2022

AbstractFullPdf
Mar 202110321032170
Apr 202125725778
May 202124924986
Jun 202117117137
Jul 202114614627
Aug 202116116025
Sep 202116216240
Oct 202114114149
Nov 202113513427
Dec 202111111112
Jan 202211912332
Feb 202210210235
Mar 202212512749
Apr 202213113325
May 2022819028
Jun 202216716735
Total32903305755